These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2093095)

  • 41. Peripheral cardiovascular effects of tabernanthine tartrate in anaesthetized rats.
    Hamon G; Castillon A; Gaignault JC; Worcel M
    Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):60-72. PubMed ID: 4051640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.
    Le Monnier de Gouville AC; Cavero I
    Br J Pharmacol; 1991 Sep; 104(1):77-84. PubMed ID: 1786522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulation of 5-HT3 receptors in the NTS inhibits the cardiac Bezold-Jarisch reflex response.
    Sévoz C; Nosjean A; Callera JC; Machado B; Hamon M; Laguzzi R
    Am J Physiol; 1996 Jul; 271(1 Pt 2):H80-7. PubMed ID: 8760161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of anaesthetic agents on pressor response to beta-blockers in the rat.
    Abdelrahman A; Wang YX; Pang CC
    J Pharm Pharmacol; 1992 Jan; 44(1):34-8. PubMed ID: 1350625
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats.
    Vayssettes-Courchay C; Bouysset F; Verbeuren TJ; Laubie M; Schmitt H
    Eur J Pharmacol; 1990 Aug; 184(1):75-85. PubMed ID: 2120077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist.
    Blackburn TP; Thornber CW; Pearce RJ; Cox B
    Eur J Pharmacol; 1988 Jun; 150(3):247-56. PubMed ID: 3416910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors.
    Saxena PR; Mylecharane EJ; Heiligers J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):121-9. PubMed ID: 2931607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
    Savci V; Cavun S; Goktalay G; Ulus IH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological characterization of 5-hydroxytryptamine-induced excitation of afferent cervical vagus nerve in anaesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Minami M; Saito H
    Br J Pharmacol; 1992 Jul; 106(3):544-9. PubMed ID: 1387026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ICI 169,369 selectively blocks 5-hydroxytryptamine2 receptors and lowers portal pressure in portal hypertensive rats.
    Kaumann AJ; Morgan JS; Groszmann RJ
    Gastroenterology; 1988 Dec; 95(6):1601-6. PubMed ID: 3181683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravenous morphine-induced activation of vagal afferents: peripheral, spinal, and CNS substrates mediating inhibition of spinal nociception and cardiovascular responses.
    Randich A; Thurston CL; Ludwig PS; Robertson JD; Rasmussen C
    J Neurophysiol; 1992 Oct; 68(4):1027-45. PubMed ID: 1432065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Participation of sympathetic and vagal tones in the hypotensive and bradycardic effects of some 5-HT1-like receptor agonists in the rat.
    Cherqui C; Dabiré H; Fournier B; Schmitt H
    Arch Int Pharmacodyn Ther; 1988; 296():18-28. PubMed ID: 2853614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microinjections of 5-HT1A agonists into the dorsal motor vagal nucleus produce a bradycardia in the atenolol-pretreated anaesthetized rat.
    Sporton SC; Shepheard SL; Jordan D; Ramage AG
    Br J Pharmacol; 1991 Oct; 104(2):466-70. PubMed ID: 1797313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system.
    Kaumann AJ; Frenken M
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1010-5. PubMed ID: 3385635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quipazine increases renin release by a peripheral hemodynamic mechanism.
    Zink MH; Pergola PE; Doane JF; Sved AF; Alper RH
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):1-9. PubMed ID: 1688963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats.
    Gardiner SM; Bennett T
    Br J Pharmacol; 1988 Jan; 93(1):9-22. PubMed ID: 2894880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular effects of irindalone, a new S2-serotonergic antagonist, in the rat.
    Gradin K; Carlsson S; Hedner T; Persson B
    Pharmacol Toxicol; 1990 Sep; 67(3):199-204. PubMed ID: 2255675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence that central 5-HT1A-receptors play a role in the von Bezold-Jarisch reflex in the rat.
    Bogle RG; Pires JG; Ramage AG
    Br J Pharmacol; 1990 Aug; 100(4):757-60. PubMed ID: 2207497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-HT2 receptor blockade by ICI 170,809 does not affect the inhibitory effect of the 5-HT1A receptor ligand gepirone on neuroleptic-induced catalepsy.
    Pires JG; Silva SR; Futuro-Neto HA
    Braz J Med Biol Res; 1994 Oct; 27(10):2437-41. PubMed ID: 7640635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of nicotine, bradykinin and veratridine to elicit cardiovascular chemoreflexes in unanaesthetized rabbits.
    Evans RG; Ludbrook J; Michalicek J
    Clin Exp Pharmacol Physiol; 1991 Apr; 18(4):245-54. PubMed ID: 2070566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.